Briefly noted: Y Hanada et al. Clin Gastroenterol Hepatol 2018; 16: 528-33.
In this retrospective review with 9247 patients with IBD, the incidence of bacterial pathogens (non-C diff) identified was <3% of those who were tested; in this group (n=25), Aeromonas was detected in 8,Salmonella in 7, Plesiomonas in 4, Campylobacter in 2, and Yersinia in 2. From authors: “These infections did not have a significant negative impact on patient outcomes. Given these findings, routine testing for infections other than CDI is not recommended.”